We have demonstrated that in the ABC and GCB, DLBCL groups revealed a decrease in CD68+, CD163+, and CD34+ cells in the GBC subgroup (Fig. 1A, B, C) of DLBCL patients respect to ABC one (Fig. 1D, E, F). This evidence concerns the gene CD163 and diffuse large B-cell lymphoma.